{"id":5350,"date":"2024-02-05T01:09:11","date_gmt":"2024-02-05T01:09:11","guid":{"rendered":"https:\/\/economicherald.net\/?p=5350"},"modified":"2024-02-05T01:09:11","modified_gmt":"2024-02-05T01:09:11","slug":"asx-health-stocks-radiopharms-results-published-promedicus-launches-on-apple-vision-pro","status":"publish","type":"post","link":"https:\/\/economicherald.net\/?p=5350","title":{"rendered":"ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro"},"content":{"rendered":"<p>Radiopharm\u2019s RAD 502 results published in paper<br \/>\nProMedicus launches product on Apple Vision Pro<br \/>\nTrivarX enhances its depression diagnostic algorithm<\/p>\n<p>\u00a0<\/p>\n<h2>Radiopharm says its drug halts tumour progression<\/h2>\n<p><strong><a href=\"https:\/\/stockhead.com.au\/company\/radiopharm-theranostics-rad\/\">Radiopharm Theranostics\u00a0(ASX:RAD)<\/a><\/strong> jumped +9% this morning after announcing that a study featuring <strong>DUNP19, (Radiopharm\u2019s RAD 502)<\/strong> shows that it can halt tumour progression and prolong survival in various cancers.<\/p>\n<p>The study was conducted by <strong>Dr David Ulmert<\/strong> and his colleagues from the <strong>University of California<\/strong>, which has now been published into a paper and available in preprint on <em>BioRxiv<\/em>.<\/p>\n<p>The study demonstrated for the very first time how DUNP19 can be used in various cancers for the detection and targeting of <strong>Leucine-Rich Repeat Containing 15 (LRRC15)<\/strong>-expressing cancers.<\/p>\n<p>LRRC15 is a cellular marker and new therapeutic target in solid tumours (breast, head and neck, lung, pancreatic), and in cancers that arise from connective tissue (osteosarcoma, glioblastoma, melanoma).<\/p>\n<p>DUNP19 (RAD 502) meanwhile is a monoclonal antibody that targets LRRC15, offering a strong potential for it to be used as an agent for treating LRRC15+ aggressive cancers.<\/p>\n<p>The findings in the paper proposed that a novel technique for imaging and treating a wide range of aggressive tumours that express LRRC15 are needed, given the limited options for targeted therapy.<\/p>\n<p>DUNP19 (RAD 502) is currently under pre-clinical investigation at Radiopharm.<\/p>\n<p>\u201cThese findings underscore the potential of radio-theranostic targeting of LRRC15 as a powerful precision medicine platform,\u201d said Dr Ulmert, Radiopharm\u2019s Scientific Advisory Board member and co-inventor of the DUNP19 platform.<\/p>\n<p>\u00a0<\/p>\n<h2>ProMedicus launches on Apple Vision Pro<\/h2>\n<p><strong><a href=\"https:\/\/stockhead.com.au\/company\/promedicus-pme\/\">ProMedicus (ASX:PME)<\/a><\/strong> said wholly owned US subsidiary, <strong>Visage Imaging<\/strong>, has launched\u00a0 <strong>Visage Ease VP<\/strong> for <strong>Apple Vision Pro<\/strong>, Apple\u2019s spatial computing platform.<\/p>\n<p>Designed to take advantage of the capabilities of Apple Vision Pro, Visage Ease VP can support immersive, spatial experiences for diagnostic imaging and multimedia.<\/p>\n<p>Apple Vision Pro is\u00a0basically a VR\/AR headset that lets you navigate using your eyes, hands, and voice.<\/p>\n<p>PME says Apple Vision Pro will enable Visage Ease VP users to use the natural and intuitive input of eyes, hands, and voice navigation to provide an imaging experience.<\/p>\n<p>\u201cThe visualisation of 3-dimensional medical imaging in immersive space creates exciting opportunities to improve patient care,\u201d said<strong> Dr. Paul Murphy<\/strong>, associate clinical professor at <em>UC San Diego School of Medicine and radiologist at UC San Diego Health.<\/em><\/p>\n<p>\u201cTechnology that allows for sophisticated eye motion and gesture controls for reviewing 2D and 3D medical imaging could potentially help in efficient tumor board reviews and create collaborative spaces in healthcare.\u201d<\/p>\n<p>UC San Diego Health is the first health system to pilot the technology.<\/p>\n<p>\u00a0<\/p>\n<h2>TrivaxX makes significant enhancements on algorithm<\/h2>\n<p><strong><a href=\"https:\/\/stockhead.com.au\/company\/trivarx-tri\/\">TrivarX (ASX:TRI)<\/a><\/strong> meanwhile said it has developed a number of improvements to its<strong> proprietary algorithm (MEB-001)<\/strong>, a diagnostic aid for current<strong> Major Depressive Episode (cMDE).<\/strong><\/p>\n<p>The enhancements followed ongoing analysis utilising\u00a0 the results from its <strong>Phase 1 Sleep Signal Analysis for Current Major Depressive Episode (SAMDE) study.<\/strong><\/p>\n<p>The enhanced algorithm (trained only on Phase 1 data) was subsequently tested on 140 full-night and split-night polysomnography (PSG) tests from Phase 2 of the study.<\/p>\n<p>Updated algorithm performance on Phase 2 data include: <strong>86% sensitivity<\/strong> \u2013 which means the ability for the test to correctly identify patients with the disease.<\/p>\n<p>The study also showed <strong>75% specificity<\/strong> \u2013 which is the ability to designate an individual who does not have the disease as negative.<\/p>\n<p>TrivarX says the results provide considerable confidence and lay strong foundation for completion of Phase 2 SAMDE study.<\/p>\n<p>\u00a0<\/p>\n<h2>Share prices today:<\/h2>\n<p>\u00a0<\/p>\n\n<p><span class=\"mce_SELRES_start\">\ufeff<\/span><span class=\"mce_SELRES_start\"><\/span>\u00a0<br \/>\n<span class=\"et_bloom_bottom_trigger\"><\/span><\/p>\n<p>The post <a href=\"https:\/\/stockhead.com.au\/health\/asx-health-stocks-radiopharms-results-published-promedicus-launches-on-apple-vision-pro\/\">ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro<\/a> appeared first on <a href=\"https:\/\/stockhead.com.au\/\">Stockhead<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Radiopharm\u2019s RAD 502 results published in paper ProMedicus launches product on Apple Vision Pro TrivarX enhances its depression diagnostic algorithm \u00a0 Radiopharm says its drug <a href=\"https:\/\/economicherald.net\/?p=5350\" class=\"read-more-link\">[more&#8230;]<\/a><\/p>\n","protected":false},"author":0,"featured_media":5351,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-5350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro - Economic Herald<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/economicherald.net\/?p=5350\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro - Economic Herald\" \/>\n<meta property=\"og:description\" content=\"Radiopharm\u2019s RAD 502 results published in paper ProMedicus launches product on Apple Vision Pro TrivarX enhances its depression diagnostic algorithm \u00a0 Radiopharm says its drug [more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/economicherald.net\/?p=5350\" \/>\n<meta property=\"og:site_name\" content=\"Economic Herald\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-05T01:09:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/02\/ProMedicus-launches-product-on-Apple-Vision-Pro.-Picture-Getty-msriiN.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=5350#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=5350\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro\",\"datePublished\":\"2024-02-05T01:09:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=5350\"},\"wordCount\":597,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=5350#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/ProMedicus-launches-product-on-Apple-Vision-Pro.-Picture-Getty-msriiN.jpeg\",\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=5350#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=5350\",\"url\":\"https:\\\/\\\/economicherald.net\\\/?p=5350\",\"name\":\"ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro - Economic Herald\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=5350#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=5350#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/ProMedicus-launches-product-on-Apple-Vision-Pro.-Picture-Getty-msriiN.jpeg\",\"datePublished\":\"2024-02-05T01:09:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=5350#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=5350\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=5350#primaryimage\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/ProMedicus-launches-product-on-Apple-Vision-Pro.-Picture-Getty-msriiN.jpeg\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/ProMedicus-launches-product-on-Apple-Vision-Pro.-Picture-Getty-msriiN.jpeg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=5350#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/economicherald.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"name\":\"Economic Herald\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/economicherald.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\",\"name\":\"Economic Herald\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"width\":850,\"height\":760,\"caption\":\"Economic Herald\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro - Economic Herald","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/economicherald.net\/?p=5350","og_locale":"en_US","og_type":"article","og_title":"ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro - Economic Herald","og_description":"Radiopharm\u2019s RAD 502 results published in paper ProMedicus launches product on Apple Vision Pro TrivarX enhances its depression diagnostic algorithm \u00a0 Radiopharm says its drug [more...]","og_url":"https:\/\/economicherald.net\/?p=5350","og_site_name":"Economic Herald","article_published_time":"2024-02-05T01:09:11+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/02\/ProMedicus-launches-product-on-Apple-Vision-Pro.-Picture-Getty-msriiN.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/economicherald.net\/?p=5350#article","isPartOf":{"@id":"https:\/\/economicherald.net\/?p=5350"},"author":{"name":"","@id":""},"headline":"ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro","datePublished":"2024-02-05T01:09:11+00:00","mainEntityOfPage":{"@id":"https:\/\/economicherald.net\/?p=5350"},"wordCount":597,"commentCount":0,"publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"image":{"@id":"https:\/\/economicherald.net\/?p=5350#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/02\/ProMedicus-launches-product-on-Apple-Vision-Pro.-Picture-Getty-msriiN.jpeg","articleSection":["Finance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/economicherald.net\/?p=5350#respond"]}]},{"@type":"WebPage","@id":"https:\/\/economicherald.net\/?p=5350","url":"https:\/\/economicherald.net\/?p=5350","name":"ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro - Economic Herald","isPartOf":{"@id":"https:\/\/economicherald.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/economicherald.net\/?p=5350#primaryimage"},"image":{"@id":"https:\/\/economicherald.net\/?p=5350#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/02\/ProMedicus-launches-product-on-Apple-Vision-Pro.-Picture-Getty-msriiN.jpeg","datePublished":"2024-02-05T01:09:11+00:00","breadcrumb":{"@id":"https:\/\/economicherald.net\/?p=5350#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/economicherald.net\/?p=5350"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/?p=5350#primaryimage","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/02\/ProMedicus-launches-product-on-Apple-Vision-Pro.-Picture-Getty-msriiN.jpeg","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/02\/ProMedicus-launches-product-on-Apple-Vision-Pro.-Picture-Getty-msriiN.jpeg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/economicherald.net\/?p=5350#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/economicherald.net\/"},{"@type":"ListItem","position":2,"name":"ASX Health Stocks: Radiopharm\u2019s results published; ProMedicus launches on Apple Vision Pro"}]},{"@type":"WebSite","@id":"https:\/\/economicherald.net\/#website","url":"https:\/\/economicherald.net\/","name":"Economic Herald","description":"","publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/economicherald.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/economicherald.net\/#organization","name":"Economic Herald","url":"https:\/\/economicherald.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","width":850,"height":760,"caption":"Economic Herald"},"image":{"@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/5350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5350"}],"version-history":[{"count":0,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/5350\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/media\/5351"}],"wp:attachment":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}